Ring K - Search Results

1

Ovarian Cancer Risk Prediction - a Clinical Epidemiology Perspective.

Wentzensen N, Ring K, Erickson BK, Reid B, O'Donnell T, Check D, Tworoger SS, Choudhury PP. Wentzensen N, et al. Among authors: ring k. Am J Epidemiol. 2024 Aug 21:kwae293. doi: 10.1093/aje/kwae293. Online ahead of print. Am J Epidemiol. 2024. PMID: 39168836

2

Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers.

Stewart ME, Knisely AT, Sullivan MW, Ring KL, Modesitt SC. Stewart ME, et al. Gynecol Oncol Rep. 2019 Feb 1;28:18-22. doi: 10.1016/j.gore.2019.01.010. eCollection 2019 May. Gynecol Oncol Rep. 2019. PMID: 30775416 Free PMC article.

3

Ovarian cancer risk in Lynch syndrome: it's time to individualise.

Ring KL. Ring KL. BJOG. 2021 Mar;128(4):737. doi: 10.1111/1471-0528.16481. Epub 2020 Sep 29. BJOG. 2021. PMID: 32892474 No abstract available.

4

Updates in gynecologic care for individuals with lynch syndrome.

Underkofler KA, Ring KL. Underkofler KA, et al. Front Oncol. 2023 Mar 1;13:1127683. doi: 10.3389/fonc.2023.1127683. eCollection 2023. Front Oncol. 2023. PMID: 36937421 Free PMC article. Review.

5

How far is too far? Cancer prevention and clinical trial enrollment in geographically underserved patient populations.

Ring KL, Duska LR. Ring KL, et al. Gynecol Oncol. 2024 May;184:8-15. doi: 10.1016/j.ygyno.2024.01.008. Epub 2024 Jan 24. Gynecol Oncol. 2024. PMID: 38271774 Review.

6

The Intersection of Endometriosis and Ovarian Cancer Prevention.

Ring KL. Ring KL. JAMA Surg. 2024 Oct 1;159(10):1103-1105. doi: 10.1001/jamasurg.2024.2974. JAMA Surg. 2024. PMID: 39141359 No abstract available.

7

Cervical cytology in endometrial cancer patients with Lynch syndrome: opportunities for early detection and limitations.

Park Y, Dibbern ME, Ring KL, Mills AM. Park Y, et al. J Am Soc Cytopathol. 2024 Nov-Dec;13(6):438-443. doi: 10.1016/j.jasc.2024.08.002. Epub 2024 Aug 10. J Am Soc Cytopathol. 2024. PMID: 39242291

8

What About the Others? Clinical Management of Gynecologic Cancer Risk in Patients With Moderate-Risk Hereditary Cancer Genes ( ATM , BRIP1 , RAD51C , RAD51D , and PALB2 ).

Goldfeld EI, Kelly BE, Ring KL. Goldfeld EI, et al. Among authors: ring kl. Clin Obstet Gynecol. 2024 Dec 1;67(4):696-701. doi: 10.1097/GRF.0000000000000897. Epub 2024 Sep 26. Clin Obstet Gynecol. 2024. PMID: 39324947 Review.

9

Current and future role of genetic screening in gynecologic malignancies.

Ring KL, Garcia C, Thomas MH, Modesitt SC. Ring KL, et al. Am J Obstet Gynecol. 2017 Nov;217(5):512-521. doi: 10.1016/j.ajog.2017.04.011. Epub 2017 Apr 12. Am J Obstet Gynecol. 2017. PMID: 28411145 Review.

10

Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction.

Ring KL, Modesitt SC. Ring KL, et al. Obstet Gynecol Clin North Am. 2018 Mar;45(1):155-173. doi: 10.1016/j.ogc.2017.10.011. Obstet Gynecol Clin North Am. 2018. PMID: 29428283 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters